Showing results (471-480 of 512) with videos related to
Sort By:
Pageof 52
Therapeutic Advances in Medical Oncology|August 24, 2023
Identification of an endogenous retroviral signature to predict anti-PD1 response in advanced clear cell renal cell carcinoma: an integrated analysis of three clinical trialsJian-Guo Zhou, Yu Zeng, Haitao Wang, et al.Cancers|September 28, 2024
Tumor-Associated Neutrophils Are a Negative Prognostic Factor in Early Luminal Breast Cancers Lacking Immunosuppressive Macrophage RecruitmentEva Schmidt, Luitpold Distel, Ramona Erber, et al.Cancers|January 11, 2022
Influence of Gender on Radiosensitivity during Radiochemotherapy of Advanced Rectal CancerBarbara Schuster, Markus Hecht, Manfred Schmidt, et al.Frontiers in Oncology|November 30, 2020
Prospective Evaluation of All-lesion Versus Single-lesion Radiotherapy in Combination With PD-1/PD-L1 Immune Checkpoint InhibitorsPhilipp Schubert, Sandra Rutzner, Markus Eckstein, et al.European Journal of Cancer (Oxford, England : 1990)|October 12, 2020
Prospective evaluation of the prognostic value of immune-related adverse events in patients with non-melanoma solid tumour treated with PD-1/PD-L1 inhibitors alone and in combination with radiotherapyClaudia Schweizer, Philipp Schubert, Sandra Rutzner, et al.Journal for Immunotherapy of Cancer|February 17, 2021
Prospective development and validation of a liquid immune profile-based signature (LIPS) to predict response of patients with recurrent/metastatic cancer to immune checkpoint inhibitorsJian-Guo Zhou, Anna-Jasmina Donaubauer, Benjamin Frey, et al.BMC Cancer|November 19, 2021
Relevance of the time interval between surgery and adjuvant radio (chemo) therapy in HPV-negative and advanced head and neck carcinoma of unknown primary (CUP)Matthias Balk, Robin Rupp, Konstantin Mantsopoulos, et al.Frontiers in Immunology|November 17, 2022
Case report: Patient specific combination of surgery and immunotherapy in advanced squamous cell carcinoma of the head and neck - a case series and review of literatureManuel Olmos, Rainer Lutz, Tjark-Ole Büntemeyer, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 13, 2025
Patient-reported outcomes in head and neck cancer: a cross-sectional analysis of quality of life domains across early and advanced UICC stagesMoritz Allner, Atina Rak, Matthias Balk, et al.Frontiers in Oncology|November 8, 2021
Predictive Value of Multiparametric MRI for Response to Single-Cycle Induction Chemo-Immunotherapy in Locally Advanced Head and Neck Squamous Cell CarcinomaKonstantin Hellwig, Stephan Ellmann, Markus Eckstein, et al.Pageof 52